Temat: "ACINETOBACTER infections" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis.
Autorzy:: Bostanghadiri N; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Narimisa N; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mirshekar M; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Dadgar-Zankbar L; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Taki E; Department of Microbiology, School of Medicine, Kermanshah University of Medical Science, Kermanshah, Iran.
Navidifar T; Department of Basic Sciences, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran. roya_.
Darban-Sarokhalil D; Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. davood_.; Pokaż więcej
Źródło:: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2024 Feb 28; Vol. 13 (1), pp. 24. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/epidemiology
Acinetobacter Infections*/drug therapy
Humans ; Colistin/pharmacology ; Colistin/therapeutic use ; Prevalence ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Anti-Acinetobacter Baumannii single-chain variable fragments provide therapeutic efficacy in an immunocompromised mouse pneumonia model.
Autorzy:: Basardeh E; Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Piri-Gavgani S; Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Moradi HR; Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Azizi M; Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Mirzabeigi P; Department of Clinical Pharmacy and Pharmacoeconomics, Faculty of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
Nazari F; Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Ghanei M; Chemical Injuries Research Center, Systems Biology and Poisoning Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mahboudi F; Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Rahimi-Jamnani F; Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran. .; Pokaż więcej
Źródło:: BMC microbiology [BMC Microbiol] 2024 Feb 10; Vol. 24 (1), pp. 55. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Single-Chain Antibodies*/pharmacology
Single-Chain Antibodies*/therapeutic use
Acinetobacter Infections*/drug therapy
Acinetobacter Infections*/microbiology
Pneumonia*/drug therapy
Pneumonia*/microbiology
Humans ; Animals ; Mice ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Drug Resistance, Multiple, Bacterial ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Antimicrobial peptide thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model.
Autorzy:: Lim J; Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yongin, 17035, Republic of Korea.
Myung H; Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yongin, 17035, Republic of Korea.; LyseNTech Co., Ltd., Seongnam-Si, 13486, Republic of Korea.
Lim D; Division of Biomedical Convergence, College of Biomedical Science, Kangwon National University, Chuncheon, 24341, Republic of Korea. .
Song M; Department of Bioscience and Biotechnology, Hankuk University of Foreign Studies, Yongin, 17035, Republic of Korea. .; Pokaż więcej
Źródło:: Journal of biomedical science [J Biomed Sci] 2024 Apr 15; Vol. 31 (1), pp. 36. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Endopeptidases*
Animals ; Mice ; Antimicrobial Peptides ; Antimicrobial Cationic Peptides ; Anti-Bacterial Agents/pharmacology ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii.
Autorzy:: Lan X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.; State Key Laboratory of Drug Delivery and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, People's Republic of China.
Qin S; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Liu H; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Guo M; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Zhang Y; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Jin X; School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, China.; Shihezi University, Xinjiang, China.
Duan X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Sun M; School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, China.; Shihezi University, Xinjiang, China.
Liu Z; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Wang W; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Zheng Q; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Liao X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China.
Chen J; State Key Laboratory of Drug Delivery and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, 300301, People's Republic of China.
Kang Y; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China. .
Xie Y; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China. .
Song X; Department of Critical Care Medicine, Department of Clinical Pharmacy, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China School of Nursing, West China Hospital, Sichuan University, Chengdu, China. .; Pokaż więcej
Źródło:: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 30; Vol. 22 (1), pp. 138. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Humans ; Tigecycline/pharmacology ; Tigecycline/therapeutic use ; Minocycline/pharmacology ; Drug Resistance, Multiple, Bacterial ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Water

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Regulation of overexpressed efflux pump encoding genes by cinnamon oil and trimethoprim to abolish carbapenem-resistant Acinetobacter baumannii clinical strains.
Autorzy:: Saleh NM; Department of Microbiology, Egyptian Drug Authority (former National Organization for Drug Control and Research (NODCAR), Giza, Egypt. .
Ezzat H; Department of Microbiology, Egyptian Drug Authority (former National Organization for Drug Control and Research (NODCAR), Giza, Egypt.
El-Sayyad GS; Microbiology and Immunology Department, Faculty of Pharmacy, Ahram Canadian University (ACU), 6th October City, Giza, Egypt. .; Department of Microbiology and Immunology, Faculty of Pharmacy, Galala University, New Galala City, Suez, Egypt. .; Drug Microbiology Lab., Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt. .
Zedan H; Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; Pokaż więcej
Źródło:: BMC microbiology [BMC Microbiol] 2024 Feb 08; Vol. 24 (1), pp. 52. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Humans ; Trimethoprim/metabolism ; Trimethoprim/pharmacology ; Trimethoprim/therapeutic use ; Cinnamomum zeylanicum/metabolism ; Bacterial Proteins/metabolism ; Anti-Bacterial Agents/therapeutic use ; Imipenem/pharmacology ; Imipenem/therapeutic use ; Microbial Sensitivity Tests ; Drug Resistance, Multiple, Bacterial/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: First report of Acinetobacter pittii acute community-acquired pneumonia in an immunocompetent patient in France following a heat wave.
Autorzy:: Souhail B; Antimicrobial Stewardship Team, Department of Prevention, Diagnosis, and Treatment of Infections, Henri Mondor University Hospital, AP-HP, 1, rue Gustave Eiffel, 94000, Créteil, France. .
Danjean M; Bacteriology and Infection Control Unit, Department of Prevention, Diagnosis, and Treatment of Infections, Henri Mondor University Hospital, AP-HP, Créteil, France.; EnvA, DYNAMYC, UPEC, Paris-Est Créteil University, EA 7380, Créteil, France.
Mercier-Darty M; Next Generation Sequencing Platform, Henri Mondor University Hospital, AP-HP, Créteil, France.
Amaddeo G; Hepatology Department, Henri Mondor University Hospital, AP-HP, Créteil, France.
Sessa A; Hepatology Department, Henri Mondor University Hospital, AP-HP, Créteil, France.
Fihman V; Bacteriology and Infection Control Unit, Department of Prevention, Diagnosis, and Treatment of Infections, Henri Mondor University Hospital, AP-HP, Créteil, France.; EnvA, DYNAMYC, UPEC, Paris-Est Créteil University, EA 7380, Créteil, France.
Galy A; Antimicrobial Stewardship Team, Department of Prevention, Diagnosis, and Treatment of Infections, Henri Mondor University Hospital, AP-HP, 1, rue Gustave Eiffel, 94000, Créteil, France.; EnvA, DYNAMYC, UPEC, Paris-Est Créteil University, EA 7380, Créteil, France.
Woerther PL; Bacteriology and Infection Control Unit, Department of Prevention, Diagnosis, and Treatment of Infections, Henri Mondor University Hospital, AP-HP, Créteil, France.; EnvA, DYNAMYC, UPEC, Paris-Est Créteil University, EA 7380, Créteil, France.
Lepeule R; Antimicrobial Stewardship Team, Department of Prevention, Diagnosis, and Treatment of Infections, Henri Mondor University Hospital, AP-HP, 1, rue Gustave Eiffel, 94000, Créteil, France.; EnvA, DYNAMYC, UPEC, Paris-Est Créteil University, EA 7380, Créteil, France.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 35. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Community-Acquired Infections*/diagnosis
Community-Acquired Infections*/drug therapy
Acinetobacter*/genetics
Acinetobacter Infections*/diagnosis
Acinetobacter Infections*/drug therapy
Acinetobacter Infections*/microbiology
Pneumonia*/diagnosis
Pneumonia*/drug therapy
Acinetobacter baumannii*
Humans ; Middle Aged ; Hot Temperature ; Anti-Bacterial Agents/therapeutic use ; France ; Microbial Sensitivity Tests
SCR Organism:: Acinetobacter pittii

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis.
Autorzy:: Arowolo MT; Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria.
Orababa OQ; School of Life Sciences, University of Warwick, Coventry, United Kingdom.
Olaitan MO; Department of Microbiology, University of Ibadan, Ibadan, Nigeria.
Osibeluwo BV; Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria.
Essiet UU; Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria.
Batholomew OH; School of Health Sciences, University of Bristol, Bristol, United Kingdom.
Ogunrinde OG; Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria.
Lagoke OA; Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria.
Soriwei JD; Department of Public Health in Microbiology, University of Bedfordshire, Luton, United Kingdom.
Ishola OD; Department of Biomedical Science, Nottingham Trent University, Nottingham, United Kingdom.
Ezeani OM; Department of Microbiology, University of Lagos, Akoka, Lagos, Nigeria.
Onishile AO; Faculty of Health Studies, School of Nursing and Healthcare Leadership, University of Bradford, West Yorkshire, England, United Kingdom.
Olumodeji E; Department of Biology, Texas Women University, Denton, TX, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Nov 28; Vol. 18 (11), pp. e0287762. Date of Electronic Publication: 2023 Nov 28 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Acinetobacter Infections*/epidemiology
Acinetobacter Infections*/microbiology
Humans ; Pseudomonas aeruginosa/genetics ; Prevalence ; Microbial Sensitivity Tests ; Systematic Reviews as Topic ; Meta-Analysis as Topic ; beta-Lactamases/genetics ; beta-Lactamases/pharmacology ; Bacterial Proteins/genetics ; Carbapenems/pharmacology ; Africa South of the Sahara/epidemiology ; Anti-Bacterial Agents/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Molecular study of blaVIM and blaIMP genes in Acinetobacter baumannii strains isolated from burn patients in Duhok City, Iraq.
Autorzy:: Khalid HM; Department of Biology, Faculty of Science, University of Zakho, Kurdistan Region, Iraq.; Pokaż więcej
Źródło:: Journal of infection in developing countries [J Infect Dev Ctries] 2024 Jan 31; Vol. 18 (1), pp. 101-105. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/microbiology
Burns*/complications
Humans ; Iraq ; Polymerase Chain Reaction/methods ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Imipenem ; beta-Lactamases/genetics ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Using time-series chest radiographs and laboratory data by machine learning for identifying pulmonary infection and colonization of Acinetobacter baumannii.
Autorzy:: Zeng Z; Department of Radiology, NanFang Hospital of Southern Medical University, Guangzhou, China.
Wu J; Department of Radiology, NanFang Hospital of Southern Medical University, Guangzhou, China.
Qin G; Department of Radiology, NanFang Hospital of Southern Medical University, Guangzhou, China.
Yu D; Department of Respiratory and Critical Care Medicine, Chronic Airways Diseases Laboratory, Nanfang Hospital of Southern Medical University, Guangzhou, China.
He Z; Department of Radiology, NanFang Hospital of Southern Medical University, Guangzhou, China.
Zeng W; Department of Radiology, NanFang Hospital of Southern Medical University, Guangzhou, China.
Zhou H; Department of Hospital Infection Management, ZhuJiang Hospital of Southern Medical University, Guangzhou, China.
Lin J; Department of Radiology, NanFang Hospital of Southern Medical University, Guangzhou, China.
Liu L; Department of Respiratory and Critical Care Medicine, Chronic Airways Diseases Laboratory, Nanfang Hospital of Southern Medical University, Guangzhou, China. .
Qi C; Department of Hospital Infection Management, NanFang Hospital of Southern Medical University, Guangzhou, China. .
Chen W; Department of Radiology, NanFang Hospital of Southern Medical University, Guangzhou, China. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2024 Jan 03; Vol. 25 (1), pp. 2. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/diagnostic imaging
Pneumonia*/drug therapy
Humans ; Retrospective Studies ; Anti-Bacterial Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Prevalence of biofilm producing Acinetobacter baumannii clinical isolates: A systematic review and meta-analysis.
Autorzy:: Gedefie A; Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Alemayehu E; Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Mohammed O; Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Bambo GM; Department of Medical Laboratory Sciences, College of Health Sciences, Mizan-Tepi University, Mizan, Ethiopia.
Kebede SS; Department of Medical Laboratory Sciences, College of Health Sciences, Mizan-Tepi University, Mizan, Ethiopia.
Kebede B; Department of Biomedical Sciences, College of Medicine and Health Sciences, Samara University, Samara, Ethiopia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Nov 30; Vol. 18 (11), pp. e0287211. Date of Electronic Publication: 2023 Nov 30 (Print Publication: 2023).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/microbiology
Humans ; Drug Resistance, Multiple, Bacterial ; Prevalence ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Biofilms ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon.
Autorzy:: Itani R; Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Riad El Solh, 1107 2809, P.O. Box: 11-5020, Beirut, Lebanon.
Khojah HMJ; Department of Pharmacy Practice, College of Pharmacy, Taibah University, P.O. Box: 30051, 41477, Madinah, Kingdom of Saudi Arabia.
Karout S; Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Riad El Solh, 1107 2809, P.O. Box: 11-5020, Beirut, Lebanon. .
Rahme D; Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Riad El Solh, 1107 2809, P.O. Box: 11-5020, Beirut, Lebanon.; INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
Hammoud L; Pharmacy Department, Hammoud Hospital University Medical Center, Sidon, Lebanon.
Awad R; Pharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Riad El Solh, 1107 2809, P.O. Box: 11-5020, Beirut, Lebanon.
Abu-Farha R; Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, P.O. Box: 11931, Amman, Jordan.
Mukattash TL; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box: 3030, Irbid, 22110, Jordan.
Raychouni H; Intensive Care Unit, Central Military Hospital, Military Healthcare, Lebanese Army, Beirut, Lebanon.; Intensive Care Unit, American University of Beirut Medical Center, Beirut, Lebanon.
El-Lakany A; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Riad El Solh, 1107 2809, P.O. Box: 11-5020, Beirut, Lebanon.; Department of Pharmacognosy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.; Pokaż więcej
Źródło:: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2023 Nov 29; Vol. 12 (1), pp. 136. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/epidemiology
Thrombocytopenia*/drug therapy
Humans ; Lebanon/epidemiology ; Drug Resistance, Multiple, Bacterial ; Anti-Bacterial Agents/therapeutic use ; Anti-Bacterial Agents/pharmacology ; Hospitals, Teaching

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study.
Autorzy:: Li J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Feng X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Lin Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Zheng Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Zhang F; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Mi Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Zhu X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Xiao Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Road, Tianjin, 300020, China. doctor_.; Tianjin Institutes of Health Science, Tianjin, 301600, China. doctor_.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Nov 14; Vol. 23 (1), pp. 796. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Acinetobacter Infections*/epidemiology
Bacteremia*/epidemiology
Cross Infection*/epidemiology
Sepsis*/drug therapy
Acinetobacter*
Neutropenia*
Humans ; Anti-Bacterial Agents/therapeutic use ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Initial indicators for the prognosis of Acinetobacter Baumannii bacteremia in children.
Autorzy:: Hong Y; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China.; Department of Pediatrics, Changshu Hospital, Nanjing University of Chinese Medicine, Suzhou, Jiangsu, China.
Lin X; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China.
Zhang C; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China.
Dong X; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China.
Lu M; Department of Pediatrics, Changshu Hospital, Nanjing University of Chinese Medicine, Suzhou, Jiangsu, China.
Huang S; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China.
Huang L; Laboratory department, Children Hospital of Soochow University, Suzhou, Jiangsu, China.
Su C; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China.
Bai Z; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China. .
Wu S; Pediatric Intensive Care Unit, Children Hospital of Soochow University, Suzhou, Jiangsu, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Sep 29; Vol. 23 (1), pp. 640. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Bacteremia*/drug therapy
Neutropenia*
Male ; Female ; Humans ; Child ; Child, Preschool ; Retrospective Studies ; Prognosis ; Anti-Bacterial Agents/therapeutic use ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Co-Existence of bla NDM-1 , bla OXA-23 , bla OXA-64 , bla PER-7 and bla ADC-57 in a Clinical Isolate of Acinetobacter baumannii from Alexandria, Egypt.
Autorzy:: Sánchez-Urtaza S; Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country, 48940 Leioa, Spain.
Ocampo-Sosa A; Microbiology Service, Health Research Institute (IDIVAL), University Hospital Marqués de Valdecilla, 39008 Santander, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Molins-Bengoetxea A; Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country, 48940 Leioa, Spain.
Rodríguez-Grande J; Microbiology Service, Health Research Institute (IDIVAL), University Hospital Marqués de Valdecilla, 39008 Santander, Spain.
El-Kholy MA; Division of Clinical and Biological Sciences, Department of Microbiology and Biotechnology, College of Pharmacy, Arab Academy for Science, Technology & Maritime Transport (AASTMT), Alexandria P.O. Box 1029, Egypt.
Hernandez M; Laboratory of Molecular Biology and Microbiology, One Health, Agrarian Technological Institute of Castile and Leon (ITACyL), 47009 Valladolid, Spain.
Abad D; Laboratory of Molecular Biology and Microbiology, One Health, Agrarian Technological Institute of Castile and Leon (ITACyL), 47009 Valladolid, Spain.
Shawky SM; Medical Research Institute, Alexandria University, Alexandria 5422031, Egypt.
Alkorta I; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country, 48940 Leioa, Spain.
Gallego L; Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country, 48940 Leioa, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 07; Vol. 24 (15). Date of Electronic Publication: 2023 Aug 07.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*/genetics
Acinetobacter Infections*/drug therapy
Humans ; Multilocus Sequence Typing ; Egypt ; Microbial Sensitivity Tests ; beta-Lactamases/genetics ; Bacterial Proteins/genetics ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility.
Autorzy:: Mezcord V; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Escalante J; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Nishimura B; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Traglia GM; Unidad de Genómica y Bioinformática, Departamento de Ciencias Biológicas, CENUR Litoral Norte, Universidad de la República, Salto 50000, Uruguay.
Sharma R; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Vallé Q; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Tuttobene MR; Área Biología Molecular, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario 2000, Argentina.; Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario 2000, Argentina.
Subils T; Instituto de Procesos Biotecnológicos y Químicos de Rosario (IPROBYQ, CONICET-UNR), Rosario 2000, Argentina.
Marin I; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Pasteran F; National Regional Reference Laboratory for Antimicrobial Resistance (NRL), Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas, ANLIS Dr. Carlos G. Malbrán, Buenos Aires 1282, Argentina.
Actis LA; Department of Microbiology, Miami University, Oxford, OH 45056, USA.
Tolmasky ME; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.
Bonomo RA; Research Service and GRECC, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106, USA.; Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Biochemistry, Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH 44106, USA.
Rao G; UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Ramirez MS; Center for Applied Biotechnology Studies, Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, CA 92831, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 21; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 21.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Acinetobacter Infections*/microbiology
Humans ; Carbapenems/pharmacology ; Carbapenems/therapeutic use ; Microbial Sensitivity Tests ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; beta-Lactamases/genetics ; Iron/pharmacology ; Cefiderocol

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Feature architecture aware phylogenetic profiling indicates a functional diversification of type IVa pili in the nosocomial pathogen Acinetobacter baumannii.
Autorzy:: Iruegas R; Applied Bioinformatics Group, Inst of Cell Biology and Neuroscience, Goethe University Frankfurt, Frankfurt am Main, Germany.
Pfefferle K; Molecular Microbiology & Bioenergetics, Institute of Molecular Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Göttig S; Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt, Germany.
Averhoff B; Molecular Microbiology & Bioenergetics, Institute of Molecular Biosciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Ebersberger I; Applied Bioinformatics Group, Inst of Cell Biology and Neuroscience, Goethe University Frankfurt, Frankfurt am Main, Germany.; Senckenberg Biodiversity and Climate Research Centre (S-BIK-F), Frankfurt am Main, Germany.; LOEWE Centre for Translational Biodiversity Genomics (TBG), Frankfurt am Main, Germany.; Pokaż więcej
Źródło:: PLoS genetics [PLoS Genet] 2023 Jul 27; Vol. 19 (7), pp. e1010646. Date of Electronic Publication: 2023 Jul 27 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Acinetobacter baumannii*/genetics
Acinetobacter baumannii*/metabolism
Cross Infection*/microbiology
Acinetobacter Infections*/microbiology
Humans ; Phylogeny ; Hospitals ; Anti-Bacterial Agents

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment.
Autorzy:: Jo J; Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
Kwon KT; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Ko KS; Department of Microbiology, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea. .; Pokaż więcej
Źródło:: Journal of biomedical science [J Biomed Sci] 2023 Jun 07; Vol. 30 (1), pp. 37. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*/genetics
Acinetobacter Infections*/drug therapy
Humans ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Colistin/pharmacology ; Colistin/therapeutic use ; Tigecycline/pharmacology ; Tigecycline/therapeutic use ; Drug Resistance, Multiple, Bacterial/genetics ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Therapeutic Prospection of Animal Venoms-Derived Antimicrobial Peptides against Infections by Multidrug-Resistant Acinetobacter baumannii : A Systematic Review of Pre-Clinical Studies.
Autorzy:: Lima WG; Programa de Pós Graduação em Medicina-Biomedicina, Faculdade Santa Casa de Belo Horizonte, Belo Horizonte 30150-250, MG, Brazil.
de Lima ME; Programa de Pós Graduação em Medicina-Biomedicina, Faculdade Santa Casa de Belo Horizonte, Belo Horizonte 30150-250, MG, Brazil.; Pokaż więcej
Źródło:: Toxins [Toxins (Basel)] 2023 Apr 03; Vol. 15 (4). Date of Electronic Publication: 2023 Apr 03.
Typ publikacji:: Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/drug therapy
Acinetobacter Infections*/microbiology
Arthropod Venoms*/pharmacology
Animals ; Antimicrobial Peptides ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Anti-Bacterial Agents/chemistry ; Drug Resistance, Multiple, Bacterial ; Microbial Sensitivity Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Serum Level of Antibodies Against Novel Acinetobacter Baumannii OmpA-selected Peptides in ICU Staff: Promise for the Future of Vaccine Development.
Autorzy:: Paydarfar S; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Abbasi MA; Firoozabadi Hospital Clinical Research Development Unit (FHCRDU), School of Medicine, Iran University Medical Science (IUMS), Tehran, Iran. .
Hashemi A; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Taheri S; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Bandehpour M; Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Department of Medical Biotechnology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Mosaffa N; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .; Pokaż więcej
Źródło:: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2023 Apr 30; Vol. 22 (2), pp. 150-162. Date of Electronic Publication: 2023 Apr 30.
Typ publikacji:: Journal Article
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/prevention & control
Humans ; Peptides ; Antibodies ; Vaccine Development ; Intensive Care Units

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Differential proteomic analysis and pathogenic effects of outer membrane vesicles derived from Acinetobacter baumannii under normoxia and hypoxia.
Autorzy:: Suzuki S; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Subsomwong P; Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Narita K; Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.; Institute for Animal Experimentation, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Kawai N; Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Ishiai T; Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Teng W; Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Sukchawalit R; Laboratory of Biotechnology, Chulabhorn Research Institute, Lak Si, Bangkok, Thailand.
Nakane A; Department of Biopolymer and Health Science, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Tasaka S; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Asano K; Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.; Department of Biopolymer and Health Science, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Mar 15; Vol. 18 (3), pp. e0283109. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Acinetobacter baumannii*
Acinetobacter Infections*/microbiology
Animals ; Mice ; Humans ; Bacterial Outer Membrane Proteins/metabolism ; Secretory Vesicles/metabolism ; Proteomics ; Hypoxia/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""ACINETOBACTER infections"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji